ArticleFrontiers in oncology2025

Anti-lipolysis-stimulated lipoprotein receptor antibody-drug conjugate to treat triple-negative breast cancer.

Zhuoxin Zora Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.